Heparin management and hemostatic risk evaluation in patients undergoing pulmonary thrombo-endarterectomy

Heparin management and hemostatic risk evaluation in patients undergoing pulmonary thrombo-endarterectomy - PTE study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42520

Enrollment

Registered

2015-10-01

Start date

2015-10-02

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pulmonary embolism

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Adult subjects (age 18-85 years) • Informed consent

Exclusion criteria

Exclusion criteria: • Re-operation • Hereditary hemoglobinopathies

Design outcomes

Primary

Measure	Time frame
Perioperative changes in the activated clotting time (ACT) and heparin concentration	—

Secondary

Measure	Time frame
Perioperative changes in thromboelastometric parameters and platelet aggregation	—

Countries

Netherlands

Outcome results